Roivant Sciences: A Biotech Growth Play With Major Ambitions
Roivant Sciences' diversified late-stage pipeline and robust financials promise significant growth potential. Read why I ...
اخبار 246 小时
Bupa Arabia, MRNA see 2 negotiated deals worth SAR 19.4M
The Saudi Exchange (Tadawul) witnessed today, Dec. 4, two negotiated deals worth SAR 19.4 million onBupa Arabia for ...
海普瑞跌1.86%，成交额4180.58万元，该股当前无连续增减仓现象，主力 ...
根据AI大模型测算海普瑞后市走势。短期趋势看，该股当前无连续增减仓现象，主力趋势不明显。主力没有控盘。中期趋势方面，下方累积一定获利筹码。近期该股有吸筹现象，但吸筹力度不强。舆情分析来看，2家机构预测目标均价7.30，低于当前价-36.96%。目前市场情绪极度悲观。
沃森生物跌3.18%，该股筹码平均交易成本为15.07元，近期筹码关注程度 ...
12月4日，沃森生物跌3.18%，成交额3.43亿元，换手率1.52%，总市值228.71亿元。 根据AI大模型测算沃森生物后市走势。短期趋势看，连续3日被主力资金减仓。主力没有控盘。中期趋势方面，上方有一定套牢筹码积压。近期筹码关注程度减弱。舆情分析来看，1家机构预测目标均价12.00，低于当前价-16.08%。目前市场情绪极度悲观。 异动分析 创新药+生物疫苗+合成生物+流感+西部大开发 1、 ...
Vaxart completes enrollment in Phase 2b study evaluating its COVID-19 pill
Vaxar announced completion of enrollment of the sentinel cohort of a Phase 2b clinical trial evaluating Vaxart’s (VXRT) oral pill COVID-19 ...
Why Is Moderna, Inc. (MRNA) Among the Best High Growth Healthcare Stocks to Invest In Now?
We recently compiled a list of the 10 High Growth Healthcare Stocks to Invest in Now. In this article, we are going to take a ...
Moderna, Inc. (MRNA): A Bull Case Theory
We came across a bullish thesis on Moderna, Inc. (MRNA) on Substack by Natan. In this article, we will summarize the bulls’ ...
来自MSN5 天
Moderna (MRNA) Stock Declines 87% in Three Years: 3 Key Points
On November 30th, exactly 3 years ago, Moderna’s ($MRNA) stock was priced at $352.43, but after losing 87.69% of its value, MRNA stock is priced ...
bovnews6 天
Why Did Berenberg Give Moderna Inc (MRNA) Stock Hold Rating?
On Tuesday, Moderna Inc (MRNA) stock saw a decline, ending the day at $42.05 which represents a decrease of $-1.61 or -3.69% from the prior close of $43.66. The stock opened at $43.13 and touched a ...